| Target Price | HK$13.39 |
| Price | HK$11.41 |
| Potential |
17.33%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target China Tower 2026 .
The average China Tower target price is HK$13.39.
This is
17.33%
register free of charge
HK$16.80
47.24%
register free of charge
HK$12.12
6.22%
register free of charge
|
|
| A rating was issued by 15 analysts: 11 Analysts recommend China Tower to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the China Tower stock has an average upside potential 2026 of
17.33%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 106.81 | 111.37 |
| 4.00% | 4.26% | |
| EBITDA Margin | 67.54% | 66.33% |
| 0.71% | 1.79% | |
| Net Margin | 10.97% | 11.78% |
| 5.81% | 7.35% |
11 Analysts have issued a sales forecast China Tower 2025 . The average China Tower sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an China Tower EBITDA forecast 2025. The average China Tower EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 China Tower Analysts have issued a net profit forecast 2025. The average China Tower net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 0.67 | 0.75 |
| 9.84% | 11.94% | |
| P/E | 15.44 | |
| EV/Sales | 2.51 |
11 Analysts have issued a China Tower forecast for earnings per share. The average China Tower EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


